ParkerVision reports 2024 net loss of $14.5M; patent case against Qualcomm remanded for trial

PARKERVISION INC

Net loss of $14.5M ($0.16 loss per share) vs net income of $9.5M ($0.11 EPS) in 2023.
Revenue drop of $25M due to absence of 2023 license settlement; operating expenses fell $10.5M.
CAFC overturned dismissal of Qualcomm patent case, remanded for jury trial; no trial date set.
Supreme Court denied ParkerVision's cert petition challenging CAFC Rule 36 use.
Cash $4.9M at Dec 31, 2024; long-term liabilities up $8.6M on contingent payment obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.